Published online ahead of print in the journal Oncogene , a study led by Josep Villanueva, an Investigator at the Vall d’Hebron Institute of Oncology (VHIO), shows that the receptor for advanced glycation end-product (RAGE) plays a key role in cellular mechanisms of plasticity in mesenchymal triple-negative breast cancer (TNBC) that transform epithelial cells into mesenchymal cells as potent drivers of cancer cell proliferation and tumor invasion.
Predicting H5N1 disease severity based on T cell responses
New research led by scientists at La Jolla Institute for Immunology (LJI) suggests that many people already have immune cells on “stand by” to fight
January 3, 2025